35 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-10.1
nxoej7v2m0itr
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
t0wczc hy66bytkzh4z
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
wvqx45x
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
q68icrxf
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
63amc
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
unfef8
7 Apr 22
Prospectus supplement
4:46pm
S-3
w8y54zn4 pfye2dio9n
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
vqtczw
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
dgbq xtgu
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
dok8 i0rescviy6hnzg3
24 Sep 21
Annual report
7:31am
424B3
zewzxddrpatb 6xvm
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-10.1
pt4aduc00mdk
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am